•  
logo
  • Home
  • Pharmaceutical R&D Services
    • Customized Stroke Models
      • Animal Modeling of Stroke
      • In Vitro Modeling of Stroke
    • Pathogenic Mechanism Analysis
      • Analysis of Ischemia-Triggered Glutamate Excitotoxicity
      • Molecular Mechanism Analysis of Oxidative Stress in Stroke
      • Analysis of Neuroinflammatory Mechanisms in Stroke
      • Molecular Mechanism Analysis of Ischemia-Reperfusion Injury
      • Cell Death Mechanism Analysis in Stroke
      • Epigenetic Mechanism Analysis in Stroke
      • Analysis of Gut Microbiota in Stroke
    • Stroke Drug Development Services
      • By Drug Modality
        • Small Molecule Drugs for Stroke
        • Neuropeptides
        • Monoclonal Antibodies for Stroke
        • Stem Cell-Based Therapies for Stroke
      • By Drug Action
        • Neuroprotective Agents Against Stroke
        • Thrombolytics for Stroke
        • Anticoagulant Drugs
        • Antiplatelet Drugs for Stroke
      • Customized Biospecimen Collection and Analysis Services
    • Drug Delivery System Development for Stroke
      • Nanoparticle-Based Drug Delivery Systems
      • Liposome-Based Drug Delivery Systems
      • Exosome-Based Drug Delivery Systems
      • Nasal Drug Delivery Systems
      • Virus-Based Gene Delivery Systems
    • Preclinical Evaluation Services
      • ADME/DMPK for Stroke Drugs
      • Drug Efficacy Testing for Stroke
      • Safety Assessment for Stroke Drugs
      • In Vitro Pharmacology for Stroke Drugs
    • Stroke Biomarker Development Services
      • Stroke-Related Protein Biomarkers
      • Stroke-Related RNA Biomarkers
      • Stroke-Related Metabolite Biomarkers
      • Stroke-Related Lipid Biomarkers
      • Stroke Biomarker Panels
  • Therapeutic Areas
    • Preclinical Ischemic Stroke Research Services
      • Thrombotic Stroke
      • Embolic Stroke
      • Cardioembolic Stroke
      • Cryptogenic Stroke
    • Preclinical Hemorrhagic Stroke Research Services
      • Intracerebral Hemorrhage
      • Subarachnoid Hemorrhage
    • Preclinical Transient Ischemic Attack Research Services
  • Virtual Booth
    • Brochures
    • Stroke Models
    • Case Studies
    • Protocols
  • Resources
    • Research Resources
    • Technical Notes
  • Company
    • Contact Us
    • About Us
    • Careers
Search

 

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Case Studies

  1. Home
  2. Virtual Booth
  3. Case Studies

Fill In This Form to Get Our Virtual Booth.

The Validated Data in Preclinical Stroke Research Models

To help clients make informed decisions, Ace Therapeutics provides comprehensive validation data for our stroke models.

Intraluminal Filament tMCAO Model

Intraluminal Filament pMCAO Model

Blood Injection Intracerebral Hemorrhage (ICH) Model

Bilateral Carotid Artery Stenosis (BCAS) Model

FeCl3-Induced Carotid Artery Thrombosis Model

Canine Ischemic Stroke Model

Blood–Brain Barrier (BBB) Chip Model

Blood–Brain Barrier (BBB) Chip Model

Neuroprotective Efficacy of Edaravone in a Rat tMCAO Model

Neuroprotective Efficacy of Edaravone in a Rat tMCAO Model

Pharmacological Study of Edaravone Treatment in Collagenase-Induced ICH Mouse Model

Pharmacological Study of Edaravone Treatment in Collagenase-Induced ICH Mouse Model

 Ace Therapeutics Preclinical CRO for Stroke

Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.

Quick Links
Home Pharmaceutical R&D Services Therapeutic Areas Resources
About us Contact us Careers
Contact Us

Copyright © 2026 Ace Therapeutics. All rights reserved.